Biography
Henry Sacks, MD, PhD, is Professor of Environmental Medicine & Public Health, Medicine (Infectious Diseases), Pediatrics, and Geriatrics, and Director of the Thomas C. Chalmers Clinical Trials Unit at Icahn School of Medicine at Mount Sinai (ISMMS). His career goals have been to apply the principles of evidence-based medicine to answer important clinical questions in areas of new scientific inquiry (including HIV infection and geriatrics). His work has been in two categories: (a) the design, conduct, and analysis of clinical trials and natural history studies to provide new data to directly answer clinical questions and (b) synthesis of existing data, by meta-analysis and decision analysis, to provide guidance for urgent clinical problems for which primary data are not (or not yet) available. He has over 25 years’ experience designing, conducting, and analyzing clinical trials and observational studies, and has been principal investigator on numerous NIH-sponsored studies. He teaches courses on methods of clinical research and runs the Research Ethics practicum in the ISMMS-Clarkson Research Ethics master’s degree program. He also works on Fogarty International Training Grants to teach clinical research ethics in Eastern Europe.
Education Background
Chemistry BA (Honors) - 1962 Williams College
Microbiology PhD - 1971 Albany Medical College
Medicine MD - 1975 Albany Medical College
Publications
Recent Articles in Peer Reviewed Journals
- Rosamond Rhodes, Jody Azzouni, Stefan Baumrin, Keith Benkov, Martin J. Blaser, Barbara Brenner, Joseph Dauben, William Earle, Lily Frank, Nada Gligorov, Joseph Goldfarb, Kurt Hirschhorn, Rochelle Hirschhorn, Ian Holzman, Debbie Indyk, Ethylin Wang Jabs, Douglas P. Lackey, Daniel A. Moros, Sean Philpott, Matthew E. Rhodes, Lynne D. Richardson, Henry S. Sacks, Abraham Schwab, Rhoda Sperling, Brett Trusko, Arnulf Zweig. De Minimis Risk: A Proposal for a New Category of Research Risk. American Journal of Bioethics, 2011;11: 1-7.
- Andreae MH, Rhodes E, Bourgoise T, Carter GM, White RS, Indyk D, Sacks H, Rhodes R. An Ethical Exploration of Barriers to Research on Controlled Drugs. Am J Bioeth. 2016 Apr;16(4):36-47. doi: 10.1080/15265161.2016.1145282.
- Andreae MH, Rhodes E, Bourgoise T, Carter GM, White RS, Indyk D, Sacks H, Rhodes R. Research With Controlled Drugs: Why and Why Not? Response to Open Peer Commentaries on "An Ethical Exploration of Barriers to Research on Controlled Drugs". Am J Bioeth. 2016 Apr;16(4):W1-3. doi: 10.1080/15265161.2016.1153170.
- Rhodes E, Bourgoise T, Carter G, White RS, Indyk D, Andreae MH, Sacks HS, Rhodes R. Stakeholder Views on Barriers to Research on Controversial Controlled Substances. J Clin Ethics. 2016 Winter;27(4):308-321.
- Rhodes R, Sacks H. Cautions for Extending Fecal Microbiota Transplantation to Other Therapeutic Uses. American Journal of Bioethics. 2017; 17(5): 46–63.
- Sacks HS, Rhodes R. Innovation in a Learning Healthcare System. American Journal of Bioethics 2019; 19(6): 19-21. DOI: 10.1080/15265161.2019.1602426.
- Andreae MH, Shah LD, Shepherd V, Sheehan M, Sacks HS, Rhodes R. Decisions on Innovation or Research for Devastating Disease. Am J Bioeth. 2021 Dec;21(12):28-31. doi: 10.1080/15265161.2021.1991042.